Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the pancreas
- Citation:
- Int J Radiat Oncol Biol Phys vol 120 (1) 111-9
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 14
- Parents:
- 3424
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, UG1CA189850, UG1CA232760, UG1CA233180, UG1CA233290, UG1CA233329; 1U24CA180803 (IROC); U10CA180868 (NRG Oncology)
- Corr. Author:
- Authors:
- Leila T. Tchelebi Diana Segovia Koren Smith Qian Shi TJ Fitzgerald Michael D. Chuong Tyler J. Zemla Eileen M. O'Reilly Jeffrey Meyerhardt Eugene J. Koay Jessica Lowenstein Ardaman Shergill Matthew HG Katz Joseph M. Herman
- Networks:
- LAPS-IL057, LAPS-MA036, LAPS-NY016, LAPS-TX035, MD015, NORTHWELL
- Study
- Alliance-A021501
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: